Skip to main content

Advertisement

ADVERTISEMENT

News

News
09/03/2024
Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Asundexian 50 mg daily was...
09/03/2024
EP Lab Digest
News
09/03/2024
European Society of Cardiology Press Release  London, United Kingdom – 1 September 2024: Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as...
European Society of Cardiology Press Release  London, United Kingdom – 1 September 2024: Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as...
European Society of...
09/03/2024
EP Lab Digest

Advertisement

News
09/03/2024
European Society of Cardiology Press Release London, United Kingdom – 1 September 2024: Telemedicine support to village doctors could hold the key to improving access to care for China’s rural elderly at risk for developing...
European Society of Cardiology Press Release London, United Kingdom – 1 September 2024: Telemedicine support to village doctors could hold the key to improving access to care for China’s rural elderly at risk for developing...
European Society of...
09/03/2024
EP Lab Digest
News
09/03/2024
European Society of Cardiology Press Release London, United Kingdom – 1 September 2024: Adherence to atrial fibrillation (AF) guideline recommendations was found to be poor in clinical practice across Europe, but a structured...
European Society of Cardiology Press Release London, United Kingdom – 1 September 2024: Adherence to atrial fibrillation (AF) guideline recommendations was found to be poor in clinical practice across Europe, but a structured...
European Society of Cardiology...
09/03/2024
EP Lab Digest
News
09/03/2024
European Society of Cardiology Press Release London, United Kingdom – 1 September 2024: Mass screening for atrial fibrillation using ECG together with heart failure biomarker does not prevent ischaemic stroke or systemic embolism...
European Society of Cardiology Press Release London, United Kingdom – 1 September 2024: Mass screening for atrial fibrillation using ECG together with heart failure biomarker does not prevent ischaemic stroke or systemic embolism...
European Society of Cardiology...
09/03/2024
EP Lab Digest

Advertisement

News
09/03/2024
European Society of Cardiology Press Release  London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial...
European Society of Cardiology Press Release  London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial...
European Society of Cardiology...
09/03/2024
EP Lab Digest
News
09/03/2024
European Society of Cardiology Press Release  London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when...
European Society of Cardiology Press Release  London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when...
European Society of Cardiology...
09/03/2024
EP Lab Digest
News
09/03/2024
European Society of Cardiology Press Release  Performing additional catheter ablations targeting diseased myocardium along with the standard approach of pulmonary vein isolation (PVI) to treat persistent atrial fibrillation (AF) does...
European Society of Cardiology Press Release  Performing additional catheter ablations targeting diseased myocardium along with the standard approach of pulmonary vein isolation (PVI) to treat persistent atrial fibrillation (AF) does...
European Society of Cardiology...
09/03/2024
EP Lab Digest

Advertisement

News
09/03/2024
Medtronic Press Release  Medtronic plc, a global leader in healthcare technology, shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and...
Medtronic Press Release  Medtronic plc, a global leader in healthcare technology, shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and...
Medtronic Press...
09/03/2024
EP Lab Digest
News
09/03/2024
European Society of Cardiology Press Release  WARSAW, Poland, Sept. 2, 2024 -- New research presented at the ESC Congress 2024 reveals that a novel artificial intelligence (AI) algorithm has significantly higher sensitivity...
European Society of Cardiology Press Release  WARSAW, Poland, Sept. 2, 2024 -- New research presented at the ESC Congress 2024 reveals that a novel artificial intelligence (AI) algorithm has significantly higher sensitivity...
European Society of Cardiology...
09/03/2024
EP Lab Digest

Advertisement